首页> 美国卫生研究院文献>Cancer Medicine >YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma

【2h】

YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma

机译：YAP1扩增作为确定性放化疗在非手术食管鳞状细胞癌中的预后因素

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Definitive chemoradiation therapy (dCRT) is the standard treatment for patients with nonsurgical esophageal squamous cell carcinoma (ESCC), yet patients have demonstrated great variations in their responses to dCRT and inevitably progressed following treatment.

机译：明确的化学放射疗法（dCRT）是非手术食管鳞状细胞癌（ESCC）患者的标准治疗方法，但患者对dCRT的反应表现出很大差异，并且不可避免地会随着治疗的进展而发展。

著录项

期刊名称 Cancer Medicine
作者
Honghai Dai; Yang W. Shao; Xiaoling Tong; Xue Wu; Jiaohui Pang; Alei Feng; Zhe Yang;
展开▼
作者单位

展开▼
年(卷),期 2020(9),5
年度 2020
页码 -1
总页数 10
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
chemoradiation therapy; esophageal squamous cell carcinoma; local recurrence‐free survival; next‐generation sequencing;

机译：化学放疗;食管鳞状细胞癌;局部无复发生存;下一代测序;

相似文献

外文文献
中文文献
专利

1. YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma [J] . Honghai Dai, Yang W. Shao, Xiaoling Tong, Cancer Medicine . 2020,第5期

机译：YAP1放大作为非静电食管鳞状细胞癌中的明确化学疗法的预后因素
2. Prognostic Factors of Salvage Esophagectomy for Residual or Recurrent Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy [J] . Yuki Kiyozumi, Naoya Yoshida, Takatsugu Ishimoto, World Journal of Surgery: Official Journal of the Societe Internationale de Chirurgie, Collegium Internationale Chirurgiae Digestivae, and of the International Association of Endocrine Surgeons . 2018,第9期

机译：剩余或复发性食管鳞状细胞癌后救死食管切除术的预后因素
3. Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study [J] . Takeshi Kawakami, Takahiro Tsushima, Katsuhiro Omae, BMC Cancer . 2018,第1期

机译：明确放化疗治疗胸腔食管鳞状细胞癌侵犯邻近器官的食管瘘危险因素：单中心病例对照研究
4. Prognostic Impact of Lymphnode Metastasis Mode in Patients with Esophageal Squamous Cell Carcinoma [C] . S. Takeno, T. Noguchi, T. Shibata, European Society for Surgical Research . 2006

机译：淋巴结转移模式在食管鳞状细胞癌患者中的预后影响
5. The prognostic potential of the epidermal growth factor receptor and nuclear factor kappa B pathways and associated therapeutic strategies in patients with squamous cell carcinoma of the head and neck. [D] . Wirth, Pamela Susan. 2010

机译：表皮生长因子受体和核因子κB通路对头颈部鳞状细胞癌患者的预后潜力及相关治疗策略。
6. Analysis of clinical outcomes and prognostic factors in patients treated with definitive chemoradiotherapy for oesophageal squamous cell carcinoma [O] . Hyehyun Jeong, Hyeon‐Su Im, Yeonghak Bang, 2021

机译：对食管鳞状细胞癌治疗患者患者临床结果及预后因素的分析
7. Prognostic analysis of salvage esophagectomy after definitive chemoradiotherapy for esophageal squamous cell carcinoma: The importance of lymphadenectomy [O] . Wang Shaohua, Tachimori Yuji, Hokamura Nobukazu, 2014

机译：食管鳞状细胞癌明确放化疗后挽救食管切除术的预后分析：淋巴结清扫术的重要性

YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma

摘要

著录项

相似文献

相关主题

期刊订阅